The effects of offering free treatment to street-recruited opioid injectors.
OBJECTIVE
The goal of this investigation was to assess the treatment entry impact of offering free treatment to street-recruited injecting opioid users, and to determine which variables differentiated subjects who entered treatment when it was free, compared to those who entered when they had to pay for treatment.


METHODS
Three hundred and sixty-two out-of-treatment opioid injectors, recruited through street outreach, were randomly assigned to receive or not receive a coupon for 90 days of free substance abuse treatment. Demographics, desire for treatment, drug use and HIV risk behaviors were assessed prior to assignment.


RESULTS
Subjects were characterized by frequent and long-term drug use, numerous arrests, a variety of behaviors that placed them at risk for HIV, and ambivalence about entering substance abuse treatment. Offering free treatment led to significantly greater treatment entry (53% vs. 33%) and retention (155 days vs. 83 days). Entry into free treatment was particularly high, compared to those who had to pay for treatment, among subjects who had never been in treatment (43% vs. 23%) and those who reported that they did not want to enter treatment (24% vs. 6%). Subjects who entered free treatment were significantly less likely to have family problems than those who paid for their treatment.


CONCLUSIONS
Opioid addicts recruited on the street and offered free methadone maintenance treatment are likely to enter and remain in treatment, even if they have never been in treatment before or claim not to want treatment. Different treatment approaches may be necessary if such subjects are motivated more by the removal of financial obstacles than other factors, such as family problems.
Kwiatkowski
C F
CF
Department of Psychiatry, University of Colorado School of Medicine, Denver 80211, USA.
Booth
R E
RE
Lloyd
L V
LV
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D013287:Illicit Drugs; D008297:Male; D008691:Methadone / Q000191:economics / Q000627:therapeutic use*; D008875:Middle Aged; D009294:Narcotics / Q000191:economics / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000191:economics / Q000534:rehabilitation*; D010349:Patient Compliance / Q000523:psychology*; D015819:Substance Abuse, Intravenous / Q000191:economics / Q000534:rehabilitation*
D013287:Illicit Drugs; D009294:Narcotics; D008691:Methadone